Search hospitals > New York > New York
Mount Sinai West
Claim this profileNew York, New York 10019
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Adenocarcinoma
Conducts research for Colorectal Cancer
Conducts research for Squamous Cell Carcinoma
113 reported clinical trials
29 medical researchers
Summary
Mount Sinai West is a medical facility located in New York, New York. This center is recognized for care of Breast Cancer, Cancer, Adenocarcinoma, Colorectal Cancer, Squamous Cell Carcinoma and other specialties. Mount Sinai West is involved with conducting 113 clinical trials across 187 conditions. There are 29 research doctors associated with this hospital, such as Thomas Marron, MD PhD, Amy D. Tiersten, Paula Klein, MD, and Joanne V Loewy.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
2Cancer
Global LeaderStage IV
Stage III
ER positive
Top PIs
Thomas Marron, MD PhDIcahn School of Medicine at Mount Sinai1 year of reported clinical research
Studies Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
24 drugs studied
Amy D. TierstenIcahn School of Medicine at Mount Sinai1 year of reported clinical research
Studies Breast Cancer
Studies Metastasis
8 reported clinical trials
17 drugs studied
Paula Klein, MDMount Sinai Beth Israel Comprehensive Cancer Center West6 years of reported clinical research
Studies Breast Cancer
Studies Breast Disease
5 reported clinical trials
11 drugs studied
Joanne V LoewyLouis Armstrong Center for Music and Medicine at Mount Sinai Health System4 years of reported clinical research
Studies Premature Birth
Studies Acute Lung Injury
5 reported clinical trials
12 drugs studied
Clinical Trials running at Mount Sinai West
Breast Cancer
Anal Cancer
Rectal Cancer
Cancer
Gastroesophageal Junction Adenocarcinoma
Squamous Cell Carcinoma
Colorectal Cancer
Prostate Cancer
Gastric Cancer
Lung Cancer
Abemaciclib + Bicalutamide
for Breast Cancer
This is an open label multicenter, Phase IB/II Study of Abemaciclib in Combination with Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
Recruiting3 awards Phase 1 & 218 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mount Sinai West?
Mount Sinai West is a medical facility located in New York, New York. This center is recognized for care of Breast Cancer, Cancer, Adenocarcinoma, Colorectal Cancer, Squamous Cell Carcinoma and other specialties. Mount Sinai West is involved with conducting 113 clinical trials across 187 conditions. There are 29 research doctors associated with this hospital, such as Thomas Marron, MD PhD, Amy D. Tiersten, Paula Klein, MD, and Joanne V Loewy.